Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Luca De Maso"'
Autor:
Sara Capolla, Federico Colombo, Luca De Maso, Prisca Mauro, Paolo Bertoncin, Thilo Kähne, Alexander Engler, Luis Núñez, Ruben Spretz, Gustavo Larsen, Michele Dal Bo, Giuseppe Toffoli, Paolo Macor
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-20 (2023)
Abstract Background Nanoparticles represent one of the most important innovations in the medical field. Among nanocarriers, polymeric nanoparticles (PNPs) attracted much attention due to their biodegradability, biocompatibility, and capacity to incre
Externí odkaz:
https://doaj.org/article/62e01429a3cc4ca498bd80beda0dc175
Autor:
Sara Bozzer, Luca De Maso, Maria Cristina Grimaldi, Sara Capolla, Michele Dal Bo, Giuseppe Toffoli, Paolo Macor
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2252 (2022)
The use of zebrafish (ZF) embryos as an in vivo model is increasingly attractive thanks to different features that include easy handling, transparency, and the absence of adaptive immunity until 4–6 weeks. These factors allow the development of xen
Externí odkaz:
https://doaj.org/article/f248b637741f42a099a224e48cca9e4f
Autor:
Paolo Macor, Paolo Durigutto, Alessandro Mangogna, Rossana Bussani, Luca De Maso, Stefano D’Errico, Martina Zanon, Nicola Pozzi, Pier Luigi Meroni, Francesco Tedesco
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 1003 (2021)
Increased levels of circulating complement activation products have been reported in COVID-19 patients, but only limited information is available on complement involvement at the tissue level. The mechanisms and pathways of local complement activatio
Externí odkaz:
https://doaj.org/article/53ef733e8653497a9b602f7e544d58e9
Autor:
Paolo Durigutto, Daniele Sblattero, Stefania Biffi, Luca De Maso, Chiara Garrovo, Gabriele Baj, Federico Colombo, Fabio Fischetti, Antonio F. Di Naro, Francesco Tedesco, Paolo Macor
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Complement activation is largely implicated in the pathogenesis of several clinical conditions and its therapeutic neutralization has proven effective in preventing tissue and organ damage. A problem that still needs to be solved in the therapeutic c
Externí odkaz:
https://doaj.org/article/97ab0481344745119af4128c212913b0
Autor:
Paolo Durigutto, Paolo Macor, Federica Ziller, Luca De Maso, Fabio Fischetti, Roberto Marzari, Daniele Sblattero, Francesco Tedesco
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58696 (2013)
Treatment of patients suffering from chronic diseases such as rheumatoid arthritis with recombinant antibodies is time consuming and fairly expensive and can be associated with side effects due to generalized depletion of the target molecule. We have
Externí odkaz:
https://doaj.org/article/4d85e3b091414bb6ac267dce6405d6db
Autor:
Giacomo P. Comi, Massimo Cugno, Sara Bonato, Pier Luigi Meroni, Luca De Maso, Mara Giordano, Samantha Griffini, Andrea Artoni, Elena Grovetti, Flora Peyvandi, Paolo Macor, Simona Mellone, Daniele Prati, Luca Valenti, Marcello Manfredi
Extremely rare reactions characterized by thrombosis and thrombocytopenia have been described in subjects that received ChAdOx1 nCoV-19 vaccination 5-16 days earlier. Although patients with vaccine-induced thrombotic thrombocytopenia (VITT) have high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c36240099908e372a63ab3c3febcae
http://hdl.handle.net/11368/3014676
http://hdl.handle.net/11368/3014676
Autor:
Federico, Colombo, Paolo, Durigutto, Luca, De Maso, Stefania, Biffi, Beatrice, Belmonte, Claudio, Tripodo, Romina, Oliva, Paola, Bardini, Giada M, Marini, Enzo, Terreno, Gabriele, Pozzato, Enrico, Rampazzo, Jessica, Bertrand, Bernd, Feuerstein, Jakub, Javurek, Jana, Havrankova, Costantino, Pitzalis, Luis, Nuñez, Pierluigi, Meroni, Francesco, Tedesco, Daniele, Sblattero, Paolo, Macor
Publikováno v:
Journal of autoimmunity. 103
Despite the advances in the treatment of rheumatoid arthritis (RA) achieved in the last few years, several patients are diagnosed late, do not respond to or have to stop therapy because of inefficacy and/or toxicity, leaving still a huge unmet need.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::329a48289d1342eecb05658e860fe2be
https://pubmed.ncbi.nlm.nih.gov/31213399
https://pubmed.ncbi.nlm.nih.gov/31213399
Autor:
Jana Havrankova, Luis Nunez, Enrico Rampazzo, Enzo Terreno, Jakub Javurek, Romina Oliva, Costantino Pitzalis, Beatrice Belmonte, Claudio Tripodo, Stefania Biffi, Paola Bardini, Pier Luigi Meroni, Bernd Feuerstein, Gabriele Pozzato, Jessica Bertrand, Giada Maria Marini, Federico Colombo, Luca De Maso, Paolo Macor, Daniele Sblattero, Paolo Durigutto, Francesco Tedesco
Despite the advances in the treatment of rheumatoid arthritis (RA) achieved in the last few years, several patients are diagnosed late, do not respond to or have to stop therapy because of inefficacy and/or toxicity, leaving still a huge unmet need.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a835458fd5d5b0dd5900e93b632834
http://hdl.handle.net/2318/1730799
http://hdl.handle.net/2318/1730799
Autor:
Mara Giordano, Luca De Maso, Laura Dell'Era, Paolo Macor, Rosa Maria Dellepiane, Massimo Cugno, Paola Pavesi, Maria Cristina Pietrogrande
Publikováno v:
Orphanet Journal of Rare Diseases
Background Deficiency of the eighth component of complement (C8) is a very rare primary immunodeficiency, associated with invasive, recurrent infections mainly caused by Neisseria species. We report functional and immunochemical C8 deficiency diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ee4466c4563471ff2b4cf9f8cd7ed3
https://pubmed.ncbi.nlm.nih.gov/27183977
https://pubmed.ncbi.nlm.nih.gov/27183977
Autor:
Pier Luigi Meroni, Paolo Macor, Maria Gerosa, Mariano Ferraresso, Maria Orietta Borghi, Paolo Durigutto, Luca De Maso, Tom Eirik Mollnes, Francesco Tedesco
To the editor: Deep vein thrombosis accompanied by pulmonary embolism and thrombotic occlusion of the cerebral and coronary arteries are common and severe complications of antiphospholipid syndrome (APS).[1][1] Antibodies against beta-2 glycoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12539ec2d4b23a5ed7ab2e35de39ca53
http://www.bloodjournal.org/content/bloodjournal/127/3/365.full.pdf
http://www.bloodjournal.org/content/bloodjournal/127/3/365.full.pdf